{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T07:21:06Z","timestamp":1790234466142,"version":"4.1.0"},"reference-count":32,"publisher":"Elsevier BV","issue":"14","license":[{"start":{"date-parts":[[2016,3,1]],"date-time":"2016-03-01T00:00:00Z","timestamp":1456790400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.fr","clinicalkey.com.au","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2016,3]]},"DOI":"10.1016\/j.vaccine.2016.02.004","type":"journal-article","created":{"date-parts":[[2016,2,10]],"date-time":"2016-02-10T05:32:41Z","timestamp":1455082361000},"page":"1643-1647","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":138,"title":["Protective and immunological behavior of chimeric yellow fever dengue vaccine"],"prefix":"10.1016","volume":"34","author":[{"given":"Scott B.","family":"Halstead","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philip K.","family":"Russell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2016.02.004_bib0160","doi-asserted-by":"crossref","first-page":"1195","DOI":"10.1056\/NEJMoa1506223","article-title":"Efficacy and long-term safety of a dengue vaccine in regions of endemic disease","volume":"373","author":"Hadinegoro","year":"2015","journal-title":"N Engl J Med"},{"key":"10.1016\/j.vaccine.2016.02.004_bib0165","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1038\/nrmicro.2015.2","article-title":"Dengue vaccine: hypotheses to understand CYD-TDV-induced protection","volume":"14","author":"Guy","year":"2016","journal-title":"Nat Rev Microbiol"},{"key":"10.1016\/j.vaccine.2016.02.004_bib0170","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1126\/science.aab4047","article-title":"PUBLIC HEALTH. Dengue vaccines at a crossroad","volume":"350","author":"Wilder-Smith","year":"2015","journal-title":"Science"},{"key":"10.1016\/j.vaccine.2016.02.004_bib0175","doi-asserted-by":"crossref","first-page":"1559","DOI":"10.1016\/S0140-6736(12)61428-7","article-title":"Protective efficacy of the recombinant, live-attenuated, CYD tetravalent dengue vaccine in Thai schoolchildren: a randomised, controlled phase 2b trial","volume":"380","author":"Sabchareon","year":"2012","journal-title":"Lancet"},{"key":"10.1016\/j.vaccine.2016.02.004_bib0180","doi-asserted-by":"crossref","first-page":"1358","DOI":"10.1016\/S0140-6736(14)61060-6","article-title":"Clinical efficacy and safety of a novel tetravalent dengue vaccine in healthy children in Asia: a phase 3, randomised, observer-masked, placebo-controlled trial","volume":"384","author":"Capeding","year":"2014","journal-title":"Lancet"},{"key":"10.1016\/j.vaccine.2016.02.004_bib0185","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1056\/NEJMoa1411037","article-title":"Efficacy of a tetravalent dengue vaccine in children in Latin America","volume":"372","author":"Villar","year":"2014","journal-title":"N Engl J Med"},{"key":"10.1016\/j.vaccine.2016.02.004_bib0190","doi-asserted-by":"crossref","first-page":"e1732","DOI":"10.1371\/journal.pntd.0001732","article-title":"Dengue infection in children in Ratchaburi, Thailand: a cohort study I. Epidemiology of symptomatic acute dengue infection in children, 2006\u20132009","volume":"6","author":"Sabchareon","year":"2012","journal-title":"PLoS Negl Trop Dis"},{"key":"10.1016\/j.vaccine.2016.02.004_bib0195","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1093\/oxfordjournals.aje.a113932","article-title":"Risk factors in dengue shock syndrome: a prospective epidemiologic study in Rayong, Thailand I. The 1980 outbreak","volume":"120","author":"Sangkawibha","year":"1984","journal-title":"Am J Epidemiol"},{"key":"10.1016\/j.vaccine.2016.02.004_bib0200","first-page":"1","article-title":"Prospective cohort studies of dengue viral transmission and severity of disease","volume":"338","author":"Endy","year":"2010","journal-title":"Curr Top Microbiol Immunol"},{"key":"10.1016\/j.vaccine.2016.02.004_bib0205","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1093\/aje\/kwf005","article-title":"Epidemiology of inapparent and symptomtic acute dengue virus infection: a prospective study of primary school children in Kamphaeng Phet Thailand","volume":"156","author":"Endy","year":"2002","journal-title":"Am J Epidemiol"},{"key":"10.1016\/j.vaccine.2016.02.004_bib0210","doi-asserted-by":"crossref","first-page":"e2462","DOI":"10.1371\/journal.pntd.0002462","article-title":"The nicaraguan pediatric dengue cohort study: incidence of inapparent and symptomatic dengue virus infections, 2004\u20132010","volume":"7","author":"Gordon","year":"2013","journal-title":"PLoS Negl Trop Dis"},{"key":"10.1016\/j.vaccine.2016.02.004_bib0215","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1016\/S0065-3527(03)60011-4","article-title":"Neutralization and antibody dependent enhancement of dengue viruses","volume":"60","author":"Halstead","year":"2003","journal-title":"Adv Virus Res"},{"key":"10.1016\/j.vaccine.2016.02.004_bib0220","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1086\/315215","article-title":"Dengue viremia titer, antibody response pattern, and virus serotype correlate with disease severity","volume":"181","author":"Vaughn","year":"2000","journal-title":"J Infect Dis"},{"key":"10.1016\/j.vaccine.2016.02.004_bib0225","first-page":"178","article-title":"Secondary dengue virus type 4 infections in Vietnam","volume":"36","author":"Buchy","year":"2005","journal-title":"Southeast Asian J Trop Med Public Health"},{"key":"10.1016\/j.vaccine.2016.02.004_bib0230","doi-asserted-by":"crossref","first-page":"e1311","DOI":"10.1371\/journal.pntd.0001311","article-title":"Preexisting Japanese encephalitis virus neutralizing antibodies and increased symptomatic dengue illness in a school-based cohort in Thailand","volume":"5","author":"Anderson","year":"2011","journal-title":"PLoS Negl Trop Dis"},{"key":"10.1016\/j.vaccine.2016.02.004_bib0235","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1016\/S1201-9712(02)90072-X","article-title":"Effect of age on outcome of secondary dengue 2 infections","volume":"6","author":"Guzman","year":"2002","journal-title":"Int J Infect Dis"},{"key":"10.1016\/j.vaccine.2016.02.004_bib0240","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1093\/aje\/152.9.793","article-title":"Epidemiologic studies on dengue in Santiago de Cuba, 1997","volume":"152","author":"Guzman","year":"2000","journal-title":"Am J Epidemiol"},{"key":"10.1016\/j.vaccine.2016.02.004_bib0245","doi-asserted-by":"crossref","first-page":"e198","DOI":"10.1016\/j.ijid.2011.09.026","article-title":"Epidemiological studies on dengue virus type 3 in Playa municipality, Havana, Cuba, 2001\u20132002","volume":"16","author":"Guzman","year":"2012","journal-title":"Int J Infect Dis"},{"key":"10.1016\/j.vaccine.2016.02.004_bib0250","doi-asserted-by":"crossref","first-page":"114ra28","DOI":"10.1126\/scitranslmed.3003084","article-title":"Dynamics of dengue disease severity determined by the interplay between viral genetics and serotype-specific immunity","volume":"3","author":"OhAinle","year":"2011","journal-title":"Sci Transl Med"},{"key":"10.1016\/j.vaccine.2016.02.004_bib0255","doi-asserted-by":"crossref","first-page":"1265","DOI":"10.3201\/eid1508.081500","article-title":"Dengue 1 virus and dengue hemorrhagic fever, French Polynesia, 2001","volume":"15","author":"Hubert","year":"2009","journal-title":"Emerg Infect Dis"},{"key":"10.1016\/j.vaccine.2016.02.004_bib0260","doi-asserted-by":"crossref","first-page":"30","DOI":"10.4269\/ajtmh.1952.1.30","article-title":"Research on dengue during World War II","volume":"1","author":"Sabin","year":"1952","journal-title":"Am J Trop Med Hyg"},{"key":"10.1016\/j.vaccine.2016.02.004_bib0265","doi-asserted-by":"crossref","first-page":"e1000139","DOI":"10.1371\/journal.pmed.1000139","article-title":"The impact of the demographic transition on dengue in Thailand: insights from a statistical analysis and mathematical modeling","volume":"6","author":"Cummings","year":"2009","journal-title":"PLoS Med"},{"key":"10.1016\/j.vaccine.2016.02.004_bib0270","doi-asserted-by":"crossref","first-page":"127","DOI":"10.4269\/ajtmh.2011.10-0476","article-title":"Epidemiological factors associated with dengue shock syndrome and mortality in hospitalized dengue patients in Ho Chi Minh City, Vietnam","volume":"84","author":"Anders","year":"2011","journal-title":"Am J Trop Med Hyg"},{"key":"10.1016\/j.vaccine.2016.02.004_bib0275","doi-asserted-by":"crossref","first-page":"910","DOI":"10.4269\/ajtmh.2007.77.910","article-title":"Analysis of repeat hospital admissions for dengue to estimate the frequency of third or fourth dengue infections resulting in admissions and dengue hemorrhagic fever, and serotype sequences","volume":"77","author":"Gibbons","year":"2007","journal-title":"Am J Trop Med Hyg"},{"key":"10.1016\/j.vaccine.2016.02.004_bib0280","doi-asserted-by":"crossref","first-page":"1026","DOI":"10.1093\/infdis\/jit273","article-title":"Reduced risk of disease during postsecondary dengue virus infections","volume":"208","author":"Olkowski","year":"2013","journal-title":"J Infect Dis"},{"key":"10.1016\/j.vaccine.2016.02.004_bib0285","doi-asserted-by":"crossref","first-page":"7229","DOI":"10.1016\/j.vaccine.2011.06.094","article-title":"From research to phase III: preclinical, industrial and clinical development of the Sanofi Pasteur tetravalent dengue vaccine","volume":"29","author":"Guy","year":"2011","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2016.02.004_bib0290","article-title":"Estimation of parameters related to vaccine efficacy and dengue transmission from two large phase III studies","author":"Coudeville","year":"2015","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2016.02.004_bib0295","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1128\/CDLI.10.4.622-630.2003","article-title":"Comparison of capture immunoglobulin M (IgM) and IgG enzyme-linked immunosorbent assay (ELISA) and nonstructural protein NS1 serotype-specific IgG ELISA for differentiation of primary and secondary dengue virus infections","volume":"10","author":"Shu","year":"2003","journal-title":"Clin Diagn Lab Immunol"},{"key":"10.1016\/j.vaccine.2016.02.004_bib0300","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1128\/JCM.02735-14","article-title":"Nonstructural protein 1-specific immunoglobulin m and g antibody capture enzyme-linked immunosorbent assays in diagnosis of flaviviral infections in humans","volume":"53","author":"Chao","year":"2015","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.vaccine.2016.02.004_bib0305","doi-asserted-by":"crossref","first-page":"154","DOI":"10.4269\/ajtmh.1983.32.154","article-title":"Original antigenic sin in dengue","volume":"32","author":"Halstead","year":"1983","journal-title":"Am J Trop Med Hyg"},{"key":"10.1016\/j.vaccine.2016.02.004_bib0315","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1128\/JVI.01826-10","article-title":"An in-depth analysis of original antigenic sin in dengue virus infection","volume":"85","author":"Midgley","year":"2011","journal-title":"J Virol."},{"key":"10.1016\/j.vaccine.2016.02.004_bib0310","doi-asserted-by":"crossref","first-page":"3746","DOI":"10.1016\/j.vaccine.2015.05.059","article-title":"Modelling the immunological response to a tetravalent dengue vaccine from multiple phase-2 trials in Latin America and South East Asia","volume":"33","author":"Dorigatti","year":"2015","journal-title":"Vaccine"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X16001304?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X16001304?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,9,15]],"date-time":"2020-09-15T05:47:42Z","timestamp":1600148862000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X16001304"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,3]]},"references-count":32,"journal-issue":{"issue":"14","published-print":{"date-parts":[[2016,3]]}},"alternative-id":["S0264410X16001304"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2016.02.004","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2016,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Protective and immunological behavior of chimeric yellow fever dengue vaccine","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2016.02.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2016 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}